BIOSPRING THE NUCLEIC ACID COMPANY

Serial Number 97099607
Registration 7375011
700

Registration Progress

Application Filed
Oct 29, 2021
Under Examination
Jan 3, 2023
Approved for Publication
Nov 8, 2022
Published for Opposition
Nov 8, 2022
Registered
Apr 30, 2024

Trademark Image

BIOSPRING THE NUCLEIC ACID COMPANY

Basic Information

Serial Number
97099607
Registration Number
7375011
Filing Date
October 29, 2021
Registration Date
April 30, 2024
Published for Opposition
November 8, 2022
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 30, 2024
Registration
Registered
Classes
042

Rights Holder

BioSpring Gesellschaft für Biotechnologie mbH

16
Address
Alt-Fechenheim 34
Frankfurt 60386
DD

Ownership History

BioSpring Gesellschaft für Biotechnologie GmbH

Original Applicant
16
Frankfurt DE

BioSpring Gesellschaft für Biotechnologie mbH

Owner at Publication
16
Frankfurt DD

BioSpring Gesellschaft für Biotechnologie mbH

Original Registrant
16
Frankfurt DD

Legal Representation

Attorney
Julie A. Katz

USPTO Deadlines

Next Deadline
1546 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240430)
Due Date
April 30, 2030
Grace Period Ends
October 30, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

36 events
Date Code Type Description Documents
Apr 30, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 30, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 26, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 25, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 8, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 8, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 7, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Feb 12, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Feb 12, 2024 GNFR O FINAL REFUSAL E-MAILED Loading...
Feb 12, 2024 CNFR W SU - FINAL REFUSAL - WRITTEN Loading...
Jan 16, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 16, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 16, 2024 ALIE A ASSIGNED TO LIE Loading...
Aug 23, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 21, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 21, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Aug 21, 2023 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Jul 25, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 3, 2023 IUAF S USE AMENDMENT FILED Loading...
Jul 25, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 3, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jan 3, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 8, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 8, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 19, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 3, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 21, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 21, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 21, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 16, 2022 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Aug 16, 2022 GPRA F PRIORITY ACTION E-MAILED Loading...
Aug 16, 2022 CPRA R PRIORITY ACTION WRITTEN Loading...
Aug 9, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 11, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 10, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 2, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific research services, namely, nucleic acid analysis; Scientific research services, namely, oligonucleotide analysis
First Use Anywhere: Apr 30, 2017
First Use in Commerce: Apr 30, 2017

Additional Information

Design Mark
The mark consists of the stylized wording "BIOSPRING" centered above the wording "THE NUCLEIC ACID COMPANY". A stylized DNA helix design with an incomplete circle surrounding the center of the helix is featured inside a circle that appears to the left of the wording.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THE NUCLEIC ACID COMPANY"